Joyce Steinberg

Enzalutamide for the Treatment of Androgen Receptor-Expressing Triple-Negative Breast Cancer.

Peter Schmid, Rita Nanda, Hirdesh Uppal, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I and biomarker study of ABT-869, a multiple receptor tyrosine kinase inhibitor, in patients with refractory solid malignancies.

Neeraj Gupta, Septian Hartono, C. Thng, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.